Zydus receives EIR for the injectables manufacturing facility at Zydus Biotech Park

14 Sep 2023 , 11:20 AM

The EIR report for the inspection conducted at the injectables production plant at the Zydus Biotech Park in Changodar, Ahmedabad, from June 5–13, 2023, has been received by Zydus Lifesciences.

It was a cGMP inspection, and there had been NIL observations at the end of it.

The Zydus Group is a cutting-edge, international life sciences firm that develops, produces, and promotes a wide range of healthcare solutions with the overall goal of giving people the freedom to live healthier and more fulfilling lives.

The organization, which has around 24000 employees globally, is driven by its purpose to open up new avenues in the life sciences by providing superior healthcare solutions that have a positive influence on people’s lives. Through ground-breaking discoveries, the group hopes to alter lives.

For feedback and suggestions, write to us at [e-mail]